UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	July 12, 2022

Accession Number:	0001140361-22-025729
Submission Type:	POS AM
CIK: 0001724344 Company Name: Entasis Therapeutics Holdings Inc. File Number: 333-258371